Index of reports
> Cases with Pyrexia (15)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cytoxan (Cyclophosphamide) where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Cytoxan side effects in
Reported by a physician from Israel on 2012-07-28
Patient:
Reactions: Febrile Neutropenia, Hyponatraemia, Pyrexia, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Placebo
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Dexamethasone
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Vincristine Sulfate
Dosage: 0.6 mg, qd
Start date: 2012-06-24
End date: 2012-06-24
Blinded Aprepitant
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Blinded Ondansetron HCL
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Cytoxan
Dosage: 172 mg, qd
Indication: Chemotherapy
Start date: 2012-06-19
End date: 2012-06-20
Ondansetron
Administration route: Oral
Indication: Prophylaxis of Nausea and Vomiting
Start date: 2012-06-18
End date: 2012-06-22
Blinded Aprepitant
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Blinded PRE Trial Therapy
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Dexamethasone
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Cisplatin
Dosage: 46.2 mg/kg, qd
Indication: Chemotherapy
Start date: 2012-06-18
End date: 2012-06-18
Blinded Aprepitant
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Vincristine Sulfate
Dosage: 0.66 mg, qd
Start date: 2012-07-01
End date: 2012-07-01
Etoposide
Dosage: 33 mg, qd
Indication: Chemotherapy
Start date: 2012-06-18
End date: 2012-06-20
Blinded PRE Trial Therapy
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Placebo
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Vincristine Sulfate
Dosage: 0.66 mg, qd
Indication: Chemotherapy
Start date: 2012-06-18
End date: 2012-06-18
Blinded Post Trial Therapy
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Blinded Aprepitant
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Blinded Ondansetron HCL
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Blinded Post Trial Therapy
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Other drugs received by patient: Dexacort (Dexamethasone Sodium Phosphate); Mesna; Resprim; Diamox
Possible Cytoxan side effects in
Reported by a physician from Israel on 2012-07-17
Patient:
Reactions: Febrile Neutropenia, Hyponatraemia, Pyrexia, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Post Trial Therapy
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Blinded Ondansetron HCL
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Placebo
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Blinded Post Trial Therapy
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Blinded PRE Trial Therapy
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Cisplatin
Dosage: 46.2 mg/kg, qd
Indication: Chemotherapy
Start date: 2012-06-18
End date: 2012-06-18
Cytoxan
Dosage: 172 mg, qd
Indication: Chemotherapy
Start date: 2012-06-19
End date: 2012-06-20
Dexamethasone
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Vincristine Sulfate
Dosage: 0.66 mg, qd
Indication: Chemotherapy
Start date: 2012-06-18
End date: 2012-06-18
Dexamethasone
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Blinded Ondansetron HCL
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Blinded PRE Trial Therapy
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Blinded Aprepitant
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Placebo
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Blinded Aprepitant
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Vincristine Sulfate
Dosage: 0.6 mg, qd
Start date: 2012-06-24
End date: 2012-06-24
Etoposide
Dosage: 33 mg, qd
Indication: Chemotherapy
Start date: 2012-06-18
End date: 2012-06-20
Ondansetron
Administration route: Oral
Indication: Prophylaxis of Nausea and Vomiting
Start date: 2012-06-18
End date: 2012-06-22
Blinded Aprepitant
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Vincristine Sulfate
Dosage: 0.66 mg, qd
Start date: 2012-07-01
End date: 2012-07-01
Blinded Aprepitant
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Other drugs received by patient: Dexacort (Dexamethasone Sodium Phosphate); Resprim; Diamox; Mesna
Possible Cytoxan side effects in 12 year old female
Reported by a physician from Argentina on 2012-05-25
Patient: 12 year old female
Reactions: Acute Lymphocytic Leukaemia, Neutropenia, Pyrexia
Adverse event resulted in: death
Drug(s) suspected as cause:
Etoposide
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-07-01
Clolar
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-07-01
Cytoxan
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-07-01
Possible Cytoxan side effects in 10 year old male
Reported by a physician from United States on 2012-05-24
Patient: 10 year old male, weighing 22.3 kg (49.1 pounds)
Reactions: Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 27 mg, qd on day 1 and 5
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-03-31
End date: 2012-05-01
Methylprednisolone Acetate
Dosage: 9.7 mg, q8h on day 4 to day 32
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-03
Etoposide
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-10
Afinitor
Dosage: 2 mg, qd on day 1 to day 32
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-03-31
End date: 2012-05-01
Oncaspar
Dosage: 2275 iu, qd on days 4 to 32
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-03-31
End date: 2012-05-01
Vincristine
Dosage: 1.4 mg, qd on day 4, 11, 18 and 25
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-03-31
End date: 2012-05-01
Cytoxan
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-10
Other drugs received by patient: Leucovorin Calcium; Ondansetron; Senna-Mint WAF; Colace; Sulfamethoxypyrazine / Trimethoprim; Ondansetron; Concerta; Calcium Carbonate; Clonidine
Possible Cytoxan side effects in male
Reported by a physician from United States on 2012-05-18
Patient: male, weighing 169.0 kg (371.8 pounds)
Reactions: Staphylococcal Infection, Conjunctivitis, Blood Culture Positive, Ear Pain, Device Related Infection, Oropharyngeal Pain, Pyrexia, Cough, Influenza Like Illness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituximab (Moab C2b8 ATI Cd20, Chimeric)
Cytoxan
Vincristine Sulfate
Doxorubicin Hydrochloride
Prednisone TAB
Possible Cytoxan side effects in 49 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-18
Patient: 49 year old female
Reactions: Pneumonia, Anaemia, Pancytopenia, Pyrexia, B Precursor Type Acute Leukaemia, Multi-Organ Failure, Death, Lymphocytosis, Dizziness, Asthenia, Septic Shock, Leukocytosis, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytoxan
Dosage: 100 mg, unk
Indication: Breast Cancer Stage II
Start date: 2008-03-01
Epirubicin
Indication: Breast Cancer Stage II
Start date: 2008-03-01
Fluorouracil
Indication: Breast Cancer Stage II
Start date: 2008-03-01
Possible Cytoxan side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-14
Patient: male, weighing 81.8 kg (180.0 pounds)
Reactions: Neuropathy Peripheral, Arthralgia, Joint Swelling, Pyrexia, Herpes Zoster
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytoxan
Start date: 2008-10-01
End date: 2009-03-01
Rituxan
Start date: 2008-10-01
End date: 2009-03-01
Pentostatin
Start date: 2008-10-01
End date: 2008-12-01
Other drugs received by patient: Immune Globulin NOS; Clarinex-D; Valtrex; Gamimune; Steroids; Cyanocobalamin; Nexium; Levoxyl; Amlodipine Besylate; Vitamin B-12; Celebrex
Possible Cytoxan side effects in male
Reported by a consumer/non-health professional from United States on 2012-04-22
Patient: male, weighing 81.8 kg (180.0 pounds)
Reactions: Neuropathy Peripheral, Joint Swelling, Arthralgia, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituxan
Pentostatin
Cytoxan
Start date: 2008-10-01
End date: 2009-03-01
Other drugs received by patient: Amlodipine Besylate; Nexium; Levoxyl; Cyanocobalamin; Valtrex; Clarinex-D; Vitamin B-12; Celebrex
Possible Cytoxan side effects in female
Reported by a individual with unspecified qualification from United States on 2012-04-18
Patient: female, weighing 96.6 kg (212.5 pounds)
Reactions: Pyrexia, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prednisone TAB
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-14
End date: 2012-02-19
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-14
End date: 2012-02-15
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-14
End date: 2012-02-15
Velcade
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-14
End date: 2011-12-27
Cytoxan
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-14
End date: 2012-02-15
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-14
End date: 2012-02-15
Possible Cytoxan side effects in 74 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-26
Patient: 74 year old male, weighing 81.2 kg (178.6 pounds)
Reactions: Excoriation, Anaemia, Hypotension, Neutropenic Sepsis, Tachycardia, Mental Status Changes, Atrial Fibrillation, Pyrexia, Fall, Cardiac Failure, Diarrhoea, Neutropenia, Cardiac Arrest, Lethargy, Cough
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Prednisone
Administration route: Oral
Start date: 2012-02-02
End date: 2012-02-15
Lasix
Indication: Cardiac Disorder
End date: 2012-02-22
Matulane
Administration route: Oral
Start date: 2012-02-02
End date: 2012-02-15
Spironolactone
Indication: Cardiac Disorder
End date: 2012-02-22
Coreg
Indication: Cardiac Disorder
End date: 2012-02-22
Cytoxan
Start date: 2012-02-09
End date: 2012-02-16
Lisinopril
Indication: Cardiac Disorder
End date: 2012-02-22
Vinblastine Sulfate
Start date: 2012-02-09
End date: 2012-02-16
Other drugs received by patient: Levofloxacin; Prevacid; Tamsulosin HCL; Klor-CON; Folic Acid; Multi-Vitamins; Bleomycin Sulfate; Dacarbazine; Lidocaine; Zofran; Doxorubicin HCL
Possible Cytoxan side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-05
Patient: 54 year old male, weighing 119.0 kg (261.8 pounds)
Reactions: Nasopharyngitis, Dyspnoea, Oropharyngeal Pain, Pyrexia, Cough
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Acyclovir Sodium
Dosage: 100 mg mwf cycle 1, then 878 d1 cycle 2-6
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-03-14
End date: 2011-08-02
Cytoxan
Dosage: 1404 mg on d1 c1-6, wks 1, 5, 9, 13, 17 and 21, intravenous (not otherwise specified)
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-03-14
End date: 2011-08-02
Campath
Dosage: 30 mg, tiw x 4 weeks, subcutaneous
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-10-31
End date: 2011-11-25
Nipent
Dosage: 9.36 mg on day 1 c1-6, intravenous (not otherwise specified)
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-03-14
End date: 2011-08-02
Other drugs received by patient: Bactrim DS; Acyclovir
Possible Cytoxan side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-23
Patient: female
Reactions: Vomiting, Posture Abnormal, Pyrexia, Muscle Spasms
Drug(s) suspected as cause:
Cytoxan
Possible Cytoxan side effects in 49 year old male
Reported by a health professional (non-physician/pharmacist) from China on 2011-11-08
Patient: 49 year old male
Reactions: Dyspnoea, Diabetes Mellitus, Folliculitis, Pseudomonas Infection, Purpura, Pyrexia, Herpes Zoster, Tremor, Pneumocystis Jiroveci Pneumonia, Fatigue, Vision Blurred, Escherichia Infection, Candidiasis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prednisone
Dosage: 70 mg, daily
Indication: Pemphigus
Cytoxan
Dosage: unk
Indication: Pemphigus
Possible Cytoxan side effects in 76 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-28
Patient: 76 year old female, weighing 66.0 kg (145.2 pounds)
Reactions: Pancytopenia, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytoxan
Dosage: 1 2 3 qcycle
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-04-19
End date: 2011-06-22
Cytoxan
Dosage: 1 2 3 qcycle
Indication: B-Cell Small Lymphocytic Lymphoma
Start date: 2011-04-19
End date: 2011-06-22
Rituxan
Dosage: 1 2 3 qcycle
Indication: B-Cell Small Lymphocytic Lymphoma
Start date: 2011-04-19
End date: 2011-06-21
Fludarabine Phosphate
Dosage: 1 2 3 qcycle
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-04-19
End date: 2011-06-22
Fludarabine Phosphate
Dosage: 1 2 3 qcycle
Indication: B-Cell Small Lymphocytic Lymphoma
Start date: 2011-04-19
End date: 2011-06-22
Rituxan
Dosage: 1 2 3 qcycle
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-04-19
End date: 2011-06-21
Possible Cytoxan side effects in 70 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-12
Patient: 70 year old female, weighing 60.0 kg (132.0 pounds)
Reactions: Arthralgia, Diarrhoea, Pyrexia, Headache
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituximab
Dosage: day 4 every 28 days x 6 cycles
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-04-19
End date: 2011-05-02
Fludarabine Phosphate
Dosage: day 1-3 every days x 6 cycles
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-04-19
End date: 2011-05-02
Cytoxan
Dosage: day1-3 every 28 days x cycle
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-04-19
End date: 2011-05-02
|